GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Cyclically Adjusted Price-to-FCF

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Cyclically Adjusted Price-to-FCF : 13.63 (As of Jun. 08, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-08), Shandong Buchang Pharmaceuticals Co's current share price is ¥15.13. Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 was ¥1.11. Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF for today is 13.63.

The historical rank and industry rank for Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:603858' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 13.25   Med: 17.64   Max: 21.08
Current: 14.13

During the past 13 years, Shandong Buchang Pharmaceuticals Co's highest Cyclically Adjusted Price-to-FCF was 21.08. The lowest was 13.25. And the median was 17.64.

SHSE:603858's Cyclically Adjusted Price-to-FCF is ranked better than
79.81% of 322 companies
in the Drug Manufacturers industry
Industry Median: 31.865 vs SHSE:603858: 14.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shandong Buchang Pharmaceuticals Co's adjusted free cash flow per share data of for the fiscal year that ended in Dec23 was ¥-0.656. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥1.11 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shandong Buchang Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Chart

Shandong Buchang Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 20.21 18.79 16.83 15.31

Shandong Buchang Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 15.31 -

Competitive Comparison of Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF falls into.



Shandong Buchang Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=15.13/1.11
=13.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Shandong Buchang Pharmaceuticals Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.656/114.7809*114.7809
=-0.656

Current CPI (Dec23) = 114.7809.

Shandong Buchang Pharmaceuticals Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 1.523 99.000 1.766
201512 1.586 100.600 1.810
201612 0.949 102.600 1.062
201712 0.440 104.500 0.483
201812 0.649 106.500 0.699
201912 1.756 111.200 1.813
202012 1.286 111.500 1.324
202112 0.802 113.108 0.814
202212 2.000 115.116 1.994
202312 -0.656 114.781 -0.656

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shandong Buchang Pharmaceuticals Co  (SHSE:603858) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Shandong Buchang Pharmaceuticals Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Traded in Other Exchanges
N/A
Address
No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000
Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines